(Q28215330)

2

0 references

Tish N Hockenberry

3

0 references

Qun Wu

4

0 references

Hena Ashar

5

0 references

Stuart Black

6

0 references

Shu Fen Wen

7

0 references

Luquan Wang

8

0 references

Paul Kirschmeier

9

0 references

W Robert Bishop

10

0 references

Loretta L Nielsen

11

0 references

Cecil B Pickett

12

0 references

Suxing Liu

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

13

0 references

language of work or name

English

0 references

publication date

18 April 2002

0 references

published in

Oncogene

0 references

volume

21

0 references

issue

17

0 references

page(s)

2613-22

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205353

p53-induced apoptosis as a safeguard against cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205353

Mechanisms of p53-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205353

Special HATs for special occasions: linking histone acetylation to chromatin assembly and gene activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205353

p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205353

Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205353

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205353

Direct examination of histone acetylation on Myc target genes using chromatin immunoprecipitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205353

Definition of a consensus binding site for p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205353

Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205353

Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205353

Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205353

Chromatin remodeling and transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205353

Transcriptional repression of the anti-apoptotic survivin gene by wild type p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205353

Transcriptional control: calling in histone deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205353

p53-mediated repression of alpha-fetoprotein gene expression by specific DNA binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205353

Control of apoptosis and mitotic spindle checkpoint by survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205353

A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205353

Transcriptional activation of the human proliferating-cell nuclear antigen promoter by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205353

Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205353

p53 binds and represses the HBV enhancer: an adjacent enhancer element can reverse the transcription effect of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205353

What's up and down with histone deacetylation and transcription?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205353

Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205353

Adenovirus-based p53 gene therapy in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205353

Wild-type p53 binds to the TATA-binding protein and represses transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205353

An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205353

The cellular response to p53: the decision between life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205353

Tumor suppressor p53: regulation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205353

21 January 2018

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205353

Analyses of p53 target genes in the human genome by bioinformatic and microarray approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205353

Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205353

Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205353

Anti-apoptosis gene, survivin, and prognosis of neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205353

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1205353

1 reference

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

1049140483

0 references

Fatcat ID

release_ijgd3yrflranhn57qqg2ayqkhy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ijgd3yrflranhn57qqg2ayqkhy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

11965534

1 reference

Consolidated OpenCitations Corpus – April 2017